Vanda Pharmaceuticals
VNDA
VNDA
115 hedge funds and large institutions have $434M invested in Vanda Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 39 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
-1
Holders Change %
-0.86%
% of All Funds
3.07%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
20
Increased
36
Reduced
39
Closed
21
Calls
$7.42M
Puts
$2.23M
Net Calls
+$5.19M
Net Calls Change
+$4.94M
Top Buyers
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
$34.3M |
| 2 |
Morgan Stanley
New York
|
$21.2M |
| 3 |
TA
Teachers Advisors
New York
|
$5.09M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
$3.96M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
$2.19M |
Top Sellers
| 1 |
Millennium Management
New York
|
$4.89M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
$9.08M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
$132K |
| 4 |
AC
Armistice Capital
New York
|
$8.95M |
| 5 |
JGC
J. Goldman & Co
New York
|
$5.19M |
